Hagop M. Kantarjian, MD of MD Anderson Cancer Center states “We are witnessing a slow motion revolution in ALL” talking about Inotuzumab.
Hagop M. Kantarjian, MD of MD Anderson Cancer Center states “We are witnessing a slow motion revolution in ALL” talking about Inotuzumab.